InsidersTradesSigma
Biofil Chemicals & Pharmaceuticals Limited Stock: price and directors' dealings · India · SEBI (PIT + SAST)
Follow the Biofil Chemicals & Pharmaceuticals Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares are quoted on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Biofil Chemicals & Pharmaceuticals Limited has published 9 insider filings. Market capitalisation: €582.9m. The latest transaction was reported on 20 March 2026 (Purchase). Among the most active insiders: MEENA SHAH. Every trade is accessible without an account.
9
Insider Decl.
0
Thresholds
·
5 ops.
Buy Volume
·
3 ops.
Sell Volume
13Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,040 of 26,134 companies
49.8
score / 100
Value44
Quality56
FCF yld-1.5%
Earn yld5.0%
EV/EBITDA15.7x
ROE14%
Gross mgn7.4%
Net mgn9.8%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 20 March 2026
Declarations9 total
32,657 sharesEquity SharesSEBI:6dcd7e5b974935aec698915cf545cbcaa6cdba35
Ideal exit: 13 Dec 2026 (T+270)
32,657 sharesEquity SharesSEBI:58fc3cf4fccd04738056a826d1bb83b815f9c09d
493,940 sharesEquity SharesSEBI:7c839c82e5ccb8ba47c61560bcf026e9d4239be0
Ideal exit: 3 Mar 2026 (T+270)
87,200 sharesEquity SharesSEBI:84b2f2c28bc7f091cc25537b17bed6bf431b4d3c
Ideal exit: 6 Dec 2024 (T+270)
87,200 sharesEquity SharesSEBI:3d294f85cc1835dcf6a77482eca4b8991c77059e
300,000 sharesEquity SharesSEBI:dba95ca628068f3fb3ed926615028e82fcae45bd
300,000 sharesEquity SharesSEBI:ccc1f575dc760d9a373728a303bd7fb6b62f10f4
Ideal exit: 26 Dec 2022 (T+270)
52,680 sharesEquity SharesSEBI:06c780a7d421cf8464a16556e647864bb8035d33
Ideal exit: 29 May 2022 (T+270)
9 of 9 declarations